Page 99 - Spring2018

2016 in the Journal of American Physicians and Surgeons, using the multiple sclerosis, Gulf War syndrome, type 1
FDA’s own figures, 11-14 mcg of injected aluminum would be toxic to a diabetes, macrophagic myofasciitis and chronic
six-pound baby with impaired kidney function, yet infants are routinely fatigue syndrome, as well as a spectrum of neu-
given 250 mcg of aluminum within twelve hours of birth via the hepatitis rological disorders such as Alzheimer’s, ALS
B vaccine. and autism spectrum disorders (ASDs).
Miller also makes the point that “babies are not the only age group ex-
posed to high levels of aluminum in vaccines.” For example, the HPV vaccine GOOD WORKS BY CMSRI
(indicated for the prevention of cervical and anal cancers and genital warts Perhaps the best library of peer-reviewed,
associated with some strains of human papillomavirus) is recommended for published studies on aluminum can be found at
use in both males and females, nine through twenty-six years of age. Ac- Children’s Medical Safety Research Institute
cording to package inserts, each 0.5-mL dose of Gardasil 9 (HPV vaccine) (CMSRI) at cmsri.org. In fact, CMSRI, founded
contains approximately 500 mcg of aluminum and two to three doses are by Claire Dwoskin, not only has a comprehen-
recommended over a six- to twelve-month period based on age. sive website featuring the most important stud-
It’s important to know that Gardasil was fast-tracked through the ies, they are dedicated to funding independent
FDA. Safety trials did not include a true placebo as “control groups” were research in hopes of providing answers to our
also injected with aluminum and pharmaceutical researchers masked growing, worldwide epidemic of chronic disease
a cascade of adverse reactions. To date, there have been over fifty-five and disability. Recently, two very important alu-
thousand adverse reactions reported to the Vaccine Adverse Event Re- minum studies were made possible by CMSRI.
porting System (VAERS), including four hundred six deaths. Funding from Dwoskin’s organization provided
Dr. Christopher Exley, researcher and profes-
THE SCIENCE sor at Keele University, and his co-workers the
When my producing partners and I set out to reveal the truth about means to examine the effects of aluminum in
aluminum in our documentary about vaccines, The Greater Good, we deceased Alzheimer’s and autism patients.
visited world-renowned aluminum expert Dr. Christopher Shaw at the One of these studies used fluorescence mi-
University of British Columbia. As the first to test the biological impact croscopy, which revealed extremely high levels
of aluminum adjuvants in 2007, Dr. Shaw and fellow researchers took of aluminum in the brains of twelve familial Al-
the same aluminum hydroxide used in vaccines and injected it into the zheimer’s disease (AD) victims. “Aluminum in
muscles of mice to see what would happen when they tried to mimic Brain Tissue in Familial Alzheimer’s Disease,”
the vaccine schedule. What they found was rapid behavioral symptoms, published December 9, 2016 in the Journal of
including not only behavioral deficits of motor function, but cognitive Trace Elements in Medicine and Biology, not
deficits as well. Later when they sacrificed the animals and looked into only confirmed the presence of aluminum in
their brains and spinal cords, they found massive damage to motor familial AD brain tissue, it also gave rise to
neurons. As Dr. Shaw explained, they “may be creating conditions for two other important conclusions. First, based on
Parkinson’s and Alzheimer’s disease, maybe not immediately, but ten, their admittedly “striking” results, the authors
twenty, thirty years down the road.” When we as filmmakers asked the suggest that genetic predisposition to AD may
FDA for a response to Dr. Shaw’s study, they said they did “not believe be accompanied by “a higher propensity to ac-
this particular paper brings to light the need for additional research that is cumulate and retain aluminum in the brain.”
not already underway.” My question to the FDA today would be, “where Second and equally important, the authors
is that research now that a decade has gone by?” report that high aluminum concentrations are
Joining the ranks with Dr. Shaw, many additional independent “highly likely” to contribute not only to early
scientists have made groundbreaking discoveries regarding aluminum onset and aggressive progress of familial AD but
adjuvants and potential injury. Some of the most prominent in the field to “all forms of AD under certain conditions.”
include Dr. Shaw’s colleague, Dr. Lucija Tomljenovic, PhD, of the Uni- (Alzheimer’s disease is expected to affect one
versity of British Columbia; Dr. Christopher Exley of Keele University; in two Americans by 2050.)
Drs. Romain Gherardi and Guillemette Crépeaux of Université Paris-Est The November 2017 issue of the Journal
Créteil; and Dr. Yehuda Shoenfeld of Tel Aviv University. of Trace Elements in Medicine and Biology
Because of their work, we now know that aluminum adjuvants may published another study by Dr. Exley and team
result in autoimmunity, long-term brain inflammation and associated titled: “Aluminum in Brain Tissue in Autism.”
neurological complications. We also know that aluminum exposures are Researchers examined the brains of five de-
connected to autoimmune diseases such as lupus, rheumatoid arthritis, ceased individuals who were diagnosed with

SPRING 2018 Wise Traditions 97